Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,059.60
(
-0.41%
)
Dow Jones
50,644.28
(
0.00%
)
Brent Oil
94.36
(
2.08%
)
Bitcoin
73,368.37
(
-2.03%
)
News Focus
News Focus
Post# of 257648
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123029
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 71811

Monday, 07/25/2011 10:59:55 AM

Monday, July 25, 2011 10:59:55 AM

Post# of 257648
Laureate is manufacturing an undisclosed FoB for “a leading generic pharmaceutical company”:

http://finance.yahoo.com/news/Laureate-Biopharma-to-Produce-prnews-2470803690.html?x=0&.v=1

Teva has a contract-manufacturing deal with Lonza (#msg-34930012), and MYL has a similar arrangement with Biocon (#msg-39119393), so we may presume that Laureate’s client is someone else.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today